Thursday, June 2, 2011

Commercial Insight: Opioids in Australia


Commercial Insight: Opioids in Australia

The Australian opioid market grew from $63m in 2005 to $137m in 2009. Its growth will slow considerably and the market will be worth $182m in 2019. As many new drugs to come on the market will be reformulations, Datamonitor assumes that these will be priced at a similar level as currently available brands in order to receive reimbursement. This means that the value of the market will stabilize.
Browse all Research Reports On : Opiodis Market
Scope
*Forecast to 2019 for marketed and late-stage pipeline opioid products in Australia.
*Assessment of Australia-specific drivers and resistors likely to impact the market.
*Future market outlook for individual products taking into account key market events, in particular patent expiry and competitor launch dates.
*Case studies examining the commercial potential of anti-abuse compounds and those in development for breakthrough cancer pain.
Highlights
The controlled-release class was the highest-selling class in 2009 with sales of $115m. The fast growth of this class in recent years, particularly between 2006 and 2008, can be almost completely attributed to the uptake of two transdermal patches and the oral drug OxyContin (oxycodone; Mundipharma).
As both OxyContin (oxycodone; Mundipharma) and Durogesic (fentanyl; Janssen-Cilag) will have to battle with the entry of generics and competing products in the oral controlled-release market, Norspan (buprenorphine; Mundipharma) will become the highest-selling drug in the Australian opioid market by 2019 with sales of $34m.
While peak sales of Actiq (fentanyl; Sigma Pharmaceuticals) were over $600m in the US, 2009 sales in Australia only reached $1m. Actiq’s limited listing on the Palliative Care Schedule does not only greatly limit its patient population, it also makes it more cumbersome for physicians to apply for authorizations and repeat prescriptions.
Reasons to Purchase
*Identify key opportunities and threats that will impact the Australian opioid market as a whole and key brands and pipeline products in particular.
*Quantify the future size and scope of the Australian opioid market and predict the performance of its key compounds.
*Understand critical success factors in growing and defending opioid brand franchises from new entrants and generics.
Related Reports:
About Us:
ReportsnReports is comprising of an online library of 75,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.
We also provide 24/7 online and offline support to our customers.
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail:  sales@reportsnreports.com
at

Opioids in Australia Market Forecast


Opioids in Australia Market Forecast

The Australian opioid market grew from $63m in 2005 to $137m in 2009. Its growth will slow considerably and the market will be worth $182m in 2019. As many new drugs to come on the market will be reformulations, Datamonitor assumes that these will be priced at a similar level as currently available brands in order to receive reimbursement. This means that the value of the market will stabilize.
Browse all Research Reports On : Opiodis Market
Reasons to Purchase
*Identify key opportunities and threats that will impact the Australian opioid market as a whole and key brands and pipeline products in particular.
*Quantify the future size and scope of the Australian opioid market and predict the performance of its key compounds.
*Understand critical success factors in growing and defending opioid brand franchises from new entrants and generics.
Related Reports:
About Us:
ReportsnReports is comprising of an online library of 75,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.
We also provide 24/7 online and offline support to our customers.

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail:  sales@reportsnreports.com
Website:  http://www.reportsnreports.com
at

Opioids Market Forecast


Opioids Market Forecast

The opioids market is set to grow from $9.6 billion in 2008 to $11.9 billion in 2018 across the seven major markets. However, the number and diversity of products in late-stage development will limit the commercial potential of individual brands simply due to saturation and price competition in each opioids market.
Browse all Research Reports On : Opiodis Market
Reasons to Purchase
  • Analysis of the likely impact that recent events will have on the future opioids market
  • Includes forecasts for the key brands, generics, and pipeline agents in the seven major markets to 2018
  • Identification of future market events that are expected to affect opioid revenues.
Related Reports:
About Us:
ReportsnReports is comprising of an online library of 75,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.
We also provide 24/7 online and offline support to our customers.
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail:  sales@reportsnreports.com

at

Pipeline and Commercial Insight: Moderate to Severe Chronic Nociceptive Pain – Anti-abuse opioids set to prosper


Pipeline and Commercial Insight: Moderate to Severe Chronic Nociceptive Pain – Anti-abuse opioids set to prosper

The moderate to severe chronic nociceptive pain market has boomed in the years since the removal of generic extended-release oxycodone from the US, growing in value to eclipse $10 billion. However, this reprieve will be short-lived with the pipeline and recently-launched drugs unable to fill the void left by generic erosion of OxyContin (controlled-release oxycodone, Purdue).
Browse all Research Reports On : Opiodis Market
Scope
  • Analysis of patient segmentation, epidemiology, current treatment approaches, the patient acquisition process and clinical unmet needs
  • Breakdown of historic (200509) and future (201019) prescription sales across the seven major markets (US, Japan, France, Germany, Italy, Spain, UK)
  • Review of key pipeline trends, issues in clinical trial design and the implications of Risk Evaluation and Mitigation Strategies required by the FDA
  • Commercial and clinical assessment of key late-stage pipeline drugs, with key opinion leader comment and region-specific sales forecasts to 2019
Highlights
Aided by continued growth of OxyContin and the launch of opioids incorporating anti-abuse technologies, the market is set to peak at $11.7 billion in 2012. Thereafter, the market will contract to reach $10.5 billion in 2019, when the effect of patent expiries on key brands offsets sales growth of new drugs.
Nucynta ER is the most clinically and commercially attractive pipeline drug, eclipsing the gold standard OxyContin. Backed by Johnson & Johnson, Nucynta ER is forecast to make a significant impact upon the market. Remoxy (extended-release oxycodone, King) and EG-P066 (extended-release morphine) are also both expected to feature as leading brands.
Expectations of the novel anti-NGF class have been dampened following revelations of the osteoarthritis-worsening side effects of tanezumab (RN624, Pfizer). Datamonitor predicts that tanezumab, an NGF monoclonal antibody, will reach the market; however, as a last line therapy in severe cancer pain.
Reasons to Purchase
  • Quantify the current and future size of the moderate to severe chronic nociceptive pain market
  • Understand the country-specific impact of key events in the moderate to severe chronic nociceptive pain market during the forecast period 2010-19
  • Identify potential licensing opportunities based on product portfolios and anticipated market needs
Related Reports:
About Us:
ReportsnReports is comprising of an online library of 75,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.
We also provide 24/7 online and offline support to our customers.

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail:  sales@reportsnreports.com
Website:  http://www.reportsnreports.com
at

Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS


Risk Evaluation and Mitigation Strategy (REMS) – Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS

GBI Research’s research, “Risk Evaluation and Mitigation Strategy (REMS) – Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS”, provides key data, information and analysis on the risk management and mitigation strategies, mandated by the FDA and being implemented by pharmaceutical companies. The report provides information on the Risk Evaluation and Mitigation Strategies (REMS), the reasons why companies implement REMS and the importance of REMS. This report provides comprehensive analysis of REMS approved up to date, components of REMS and safety issues involved in the requirement of REMS using case studies. Also, information on major drug classes that require REMS such as opioids and erythropoesis-stimulating agents in cancer management is also provided in detail. The report also reviews the impact of REMS on various stakeholders including patients, healthcare providers and pharma and biotech industries. Selected REMS consulting companies are covered in the report.
Buy Now: Risk Evaluation and Mitigation Strategy Market
Browse all Research Reports On : Opiodis Market
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.
The increasing number of deaths due to adverse reactions has been alarming and has forced the FDA to implement strict regulatory guidelines for drug use. For every drug approved by the FDA, potential risks or adverse reactions of the drug are communicated to the patients and physicians through product package inserts. However, drug withdrawals such as the highly publicized Vioxx withdrawal in 2004 brought the FDA under scrutiny and highlighted the need for fundamental changes in the system.
Scope
- Analysis and data on REMS, detailed review of the drug development and pharmacovigilence studies, the need for REMS and implementation of the Food and Drug Administration and Amendments Act (FDAAA) by the FDA
- Insight into the number of approved and deemed REMS since the FDAAA came into effect.
- Components of REMS and the increasing complexity of the same.
- Analysis of the safety issues and different therapy areas that have seen REMS approvals.
- Detailed analysis of important drug classes that require REMS including opioids, and erythropoesis-stimulating agents in cancer management.
- Overview of consulting companies that offer risk management services and selected case studies.

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Build understanding of REMS for current drugs on the market and the need for REMS for new drugs and the process of submission.
- Develop effective business strategies related to risk mitigation and management of present drugs on the market and drugs in the pipeline that may require REMS.
- Analyze the safety issues and drugs in key therapy areas that require REMS and develop effective strategies to prevent a drug’s withdrawal from the market.
- Identify the key consulting companies that offer risk management solutions.
- Identify and understand various IT tools for effective data management and as a result, easy documentation of REMS.

Related Reports:
About Us:
ReportsnReports is comprising of an online library of 75,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.
We also provide 24/7 online and offline support to our customers.
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail:  sales@reportsnreports.com
Website: http://www.reportsnreports.com
at

Wednesday, June 1, 2011

Batteries and Ultra-Capacitors for the Smart Power Grid: Market Opportunities 2009-2016


Batteries and Ultra-Capacitors for the Smart Power Grid: Market Opportunities 2009-2016

Batteries and Ultra-Capacitors for the Smart Power Grid: Market Opportunities 2009-2016 - While the current electrical grid is a modern marvel, the smart grid of the future will include significant electrical storage as part of the solution to increase the grids efficiency, enhance reliability, and help reduce the environmental impact of supplying the electrical power needs of modern society. As a result, we believe chemical batteries, ultra-capacitors, and the materials from which they are built represent an exciting business opportunity that is poised to take off in the near future. This report is designed to quantify that opportunity and identify the best strategies to capitalize on it.
Buy Now: Smart Power Grid Market
Browse All: Market Research Reports
By 2016 there will be 33 GW of generating capacity on the grid from solar panels and wind farms that can swing wildly in their ability to generate electrical power at any given time. Electrical storage will be a requirement to level the load when the sun doesn't shine or the wind doesn't blow in a predictable manner. In addition to load leveling, grid storage will allow peak shaving where stored electricity from non peak demand periods can be used during peak load times. Peak shaving can reduce the need for new power plants and reduce the grids overall carbon footprint.
Chemical batteries and ultra-capacitors represent complimentary pieces of the smart grid storage equation with ultra-capacitors used for smoothing short term disruptions in power quality and batteries storing current for longer term load leveling and peak shaving applications. While other technologies such as hydro and compressed air storage will certainly be integral parts to the overall storage solution, batteries and ultra-capacitor storage represent a large attractive near term materials growth sector.
This new market study of materials for chemical batteries and ultra-capacitors for smart grid applications surveys and analyzes the markets for the various battery and ultra-capacitor types currently in use and about to enter service in smart grid applications as well as R&D developments, including those related to systems. As with all our reports, this report includes a detailed eight year forecast of materials for smart grid storage applications and an in-depth discussion of key firms active in the area.
Table Of Contents
E.1 Introduction: Smart-Grid Storage and Materials Opportunities
E.1.1 Overview of Smart Grid and Role of Energy Storage
E.1.2 Current Energy Storage Options
E.2 Opportunities for Materials Producers
E.3 Key Firms to Watch in the Smart-Grid Energy Storage Landscape
E.3.1 Lead Acid-Based Energy Storage Companies
E.3.2 Lead Carbon-Based Energy Storage Companies
E.3.3 Sodium Sulfur-Based Energy Storage Companies
E.3.4 Flow Battery Based Energy Storage Companies
E.3.5 Supercapacitor-Based Energy Storage Companies
E.4 Summary of Forecasts
Chapter One: Introduction
1.1 Background to This Report
1.1.1 Quick Tour of Opportunities in Smart Grid Storage
1.1.2 Near-Term Applications for Chemical Storage on the Smart Grid
1.1.3 Future Advantages of Chemical Storage on the Smart Grid
1.2 Objective and Scope of this Report
1.3 Methodology of this Report
1.4 Plan of this Report
Chapter Two: Materials and Technology for Smart-Grid Storage
2.1 Introduction: Crucial Need for Advanced Storage Solutions
2.1.1 Overview of the Smart Grid
2.1.2 Why We Need Smart-Grid Storage
2.1.3 Smart-Grid Storage Options: Batteries and Supercapacitors
2.1.4 Materials Opportunities in Smart-Grid Storage
2.1.5 Terms and Definitions
2.2 Traditional Grid Storage Solutions
2.2.1 Lead Acid and Advanced Lead Acid Batteries
2.2.2 Metal Hydride Batteries
2.2.3 Sodium Sulfur Batteries
2.3 Advanced Grid Storage Solutions
2.3.1 Vanadium Redox and Other Redox Flow Battery Systems
2.3.2 Zinc Bromine and Other Hybrid Flow Battery Systems
2.3.3 Lithium-Ion Batteries
2.3.4 Liquid Metal Batteries
2.3.5 Ultrabatteries
2.3.6 Chemical Storage Materials Roadmap
2.4 Supercapacitors and the Smart Grid
2.4.1 Supercapacitors: Current Technologies and Applications
2.4.2 Supercapacitor Applications in a Smart Grid
2.4.3 Supercapacitor Materials Roadmap
2.5 Key Points in this Chapter
Related Reports:
Global Drug Eluting Stents Market 2010-2014
Global Electric Vehicle Charging Station Market 2010-2014
Global Infusion Pumps and Accessory Sets 2010-2014
Global Market for High Power RF Semiconductors in Base Station Segment 2010-2014
Global Product Lifecycle Management Software Market 2010-2014
About Us:
ReportsnReports is comprising of an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.
We also provide 24/7 online and offline support to our customers.
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail:  sales@reportsnreports.com
Website:  http://www.reportsnreports.com
at

Global Security Software for Financial Services Market 2010-2014


Global Security Software for Financial Services Market 2010-2014 

TechNavio analysts forecast that the Global Security Software for Financial Services market will reach $6.9 billion in 2014. One of the key factors contributing to the growth of this market is rising compliance requirements and the penalty attached to compliance breaches. However, a lack of coordination among different departments, which may lead to the failure of the solution, could be a challenge to the growth of this market.
Buy Now: Software for Financial Services Market
Browse All: Market Research Reports
The Security Software for Financial Services market has also been witnessing a convergence of security solutions. Key vendors dominating this market space include Symantec, McAfee, IBM, and Trend Micro.
TechNavio’s report, Global Security Software for Financial Services Market 2010-2014, has been prepared based on in-depth qualitative and quantitative analysis of the market with inputs from industry experts. The report focuses on Americas, EMEA, and APAC and profiles vendors offering services to Financial Services companies.
Key questions answered in this report:
  • What will the market size be in 2014 and at what rate will it grow?
  • What key trends will this market witness?
  • What are the key factors driving market growth?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the opportunities and threats faced by each of these key vendors?
  • What are the strengths and weaknesses of each of these key vendors?
Table Of Contents
1. Executive Summary
2. Introduction
3. Market Landscape
4. Vendor Landscape
5. Market Growth Drivers
6. Market Challenges
7. Market Trends
8. Key Vendor Analysis 
8.1 Symantec Corp.
8.2 McAfee Inc.
8.3 IBM Corp.
8.4 Trend Micro Inc.
9. Other Reports in this Series

List of Exhibits
Exhibit 1: Global Security Software for Financial Services Market 2010 - 2014 (US $ Billion)
Exhibit 2: Geographic Segmentation
Exhibit 3: Vendor Segmentation
Related Reports:
About Us:
ReportsnReports is comprising of an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.
We also provide 24/7 online and offline support to our customers.

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail:  sales@reportsnreports.com
Website:  http://www.reportsnreports.com

at
Subscribe to: Posts (Atom)